X
Cookie Policy

CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our Privacy Policy for more information.

  • About
    • About The Event
  • Agenda
    • Get Involved
    • Programs
    • Search Agenda
    • In-Person Breakouts
    • Short Courses
    • Plenary Sessions
    • Speaker Biographies
    • Training Seminar
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
    • Best of Show Awards
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target 2025

2025 Conference Programs
» VIEW EVENT AT-A-GLANCE

September 22

Covalent Chemistries & Induced Proximity
Strategies for Targeting Kinases
Emerging Immune Modulation Strategies
3D Models & NAMs in Drug Development
Synthetic Biology for Drug Discovery & Development

September 23-24

Degraders & Molecular Glues – Part 1
Emerging Drug Targets: Identification & Validation
Small Molecules for Cancer Targets
Antibodies Against Membrane Protein Targets
RNA & DNA Targeting Small Molecule Drugs
AI/ML-Enabled Drug Discovery - Part 1
Targeting MASH & Obesity NEW
TS8: Know Your GPCR Molecule: Four Most Common Causes of Drug Candidate Failure

September 24-25

Degraders & Molecular Glues – Part 2
Lead Generation Strategies
Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
GPCR-Based Drug Discovery
Targeting Transcription Factors & Regulators
AI/ML-Enabled Drug Discovery - Part 2
TS7: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics
Final Agenda Now Available

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy